BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26627015)

  • 21. Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus.
    Gavvovidis I; Leisegang M; Willimsky G; Miller N; Nghiem P; Blankenstein T
    Clin Cancer Res; 2018 Aug; 24(15):3644-3655. PubMed ID: 29669806
    [No Abstract]   [Full Text] [Related]  

  • 22. Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma.
    Waltari M; Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
    Int J Cancer; 2011 Aug; 129(3):619-28. PubMed ID: 20949558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus.
    Shuda M; Feng H; Kwun HJ; Rosen ST; Gjoerup O; Moore PS; Chang Y
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16272-7. PubMed ID: 18812503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
    Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
    Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.
    Knepper TC; Montesion M; Russell JS; Sokol ES; Frampton GM; Miller VA; Albacker LA; McLeod HL; Eroglu Z; Khushalani NI; Sondak VK; Messina JL; Schell MJ; DeCaprio JA; Tsai KY; Brohl AS
    Clin Cancer Res; 2019 Oct; 25(19):5961-5971. PubMed ID: 31399473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway.
    Goyal B; Duncavage EJ; Martinez D; Lewis JS; Chernock RD
    Exp Mol Pathol; 2014 Dec; 97(3):572-8. PubMed ID: 25446844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of PI3K signaling in Merkel cell carcinoma.
    Nardi V; Song Y; Santamaria-Barria JA; Cosper AK; Lam Q; Faber AC; Boland GM; Yeap BY; Bergethon K; Scialabba VL; Tsao H; Settleman J; Ryan DP; Borger DR; Bhan AK; Hoang MP; Iafrate AJ; Cusack JC; Engelman JA; Dias-Santagata D
    Clin Cancer Res; 2012 Mar; 18(5):1227-36. PubMed ID: 22261808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the PI3K/AKT pathway in Merkel cell carcinoma.
    Hafner C; Houben R; Baeurle A; Ritter C; Schrama D; Landthaler M; Becker JC
    PLoS One; 2012; 7(2):e31255. PubMed ID: 22363598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load.
    Leroux-Kozal V; Lévêque N; Brodard V; Lesage C; Dudez O; Makeieff M; Kanagaratnam L; Diebold MD
    Hum Pathol; 2015 Mar; 46(3):443-53. PubMed ID: 25623078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens.
    Willmes C; Adam C; Alb M; Völkert L; Houben R; Becker JC; Schrama D
    Cancer Res; 2012 Apr; 72(8):2120-8. PubMed ID: 22389452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.
    Pulitzer MP; Brannon AR; Berger MF; Louis P; Scott SN; Jungbluth AA; Coit DG; Brownell I; Busam KJ
    Mod Pathol; 2015 Aug; 28(8):1023-32. PubMed ID: 26022453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence in situ hybridization and qPCR to detect Merkel cell polyomavirus physical status and load in Merkel cell carcinomas.
    Haugg AM; Rennspiess D; zur Hausen A; Speel EJ; Cathomas G; Becker JC; Schrama D
    Int J Cancer; 2014 Dec; 135(12):2804-15. PubMed ID: 24771111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen.
    Angermeyer S; Hesbacher S; Becker JC; Schrama D; Houben R
    J Invest Dermatol; 2013 Aug; 133(8):2059-64. PubMed ID: 23439392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Merkel cell polyomavirus infection in both components of a combined Merkel cell carcinoma and basal cell carcinoma with ductal differentiation; each component had a similar but different novel Merkel cell polyomavirus large T antigen truncating mutation.
    Iwasaki T; Kodama H; Matsushita M; Kuroda N; Yamasaki Y; Murakami I; Yamamoto O; Hayashi K
    Hum Pathol; 2013 Mar; 44(3):442-7. PubMed ID: 23260328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
    Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
    Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Merkel cell carcinoma: recent insights and new treatment options.
    Schrama D; Ugurel S; Becker JC
    Curr Opin Oncol; 2012 Mar; 24(2):141-9. PubMed ID: 22234254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis.
    Sastre-Garau X; Peter M; Avril MF; Laude H; Couturier J; Rozenberg F; Almeida A; Boitier F; Carlotti A; Couturaud B; Dupin N
    J Pathol; 2009 May; 218(1):48-56. PubMed ID: 19291712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells.
    Houben R; Adam C; Baeurle A; Hesbacher S; Grimm J; Angermeyer S; Henzel K; Hauser S; Elling R; Bröcker EB; Gaubatz S; Becker JC; Schrama D
    Int J Cancer; 2012 Feb; 130(4):847-56. PubMed ID: 21413015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas.
    Iwasaki T; Matsushita M; Nonaka D; Kuwamoto S; Kato M; Murakami I; Nagata K; Nakajima H; Sano S; Hayashi K
    Hum Pathol; 2015 Feb; 46(2):210-6. PubMed ID: 25466966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of significant morphologic characteristics in distinguishing between Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative Merkel cell carcinomas.
    Iwasaki T; Matsushita M; Kuwamoto S; Kato M; Murakami I; Higaki-Mori H; Nakajima H; Sano S; Hayashi K
    Hum Pathol; 2013 Sep; 44(9):1912-7. PubMed ID: 23664542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.